These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 29263650

  • 1. Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.
    Tan S, Wang G.
    Drug Des Devel Ther; 2017; 11():3519-3529. PubMed ID: 29263650
    [Abstract] [Full Text] [Related]

  • 2. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
    Wang X, Zhang M, Zhang L, Li L, Li S, Wang C, Su Z, Yuan Y, Pan W.
    Chemistry; 2017 May 11; 23(27):6586-6595. PubMed ID: 28218434
    [Abstract] [Full Text] [Related]

  • 3. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib.
    Fathi M, Sahandi Zangabad P, Barar J, Aghanejad A, Erfan-Niya H, Omidi Y.
    Int J Biol Macromol; 2018 Jan 11; 106():266-276. PubMed ID: 28802850
    [Abstract] [Full Text] [Related]

  • 4. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y, Wang Y, Liu X, Zhou J, Wang X, Feng H, Liu H.
    Drug Des Devel Ther; 2020 Jan 11; 14():5205-5215. PubMed ID: 33268983
    [Abstract] [Full Text] [Related]

  • 5. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.
    Shen Y, Li W.
    Drug Des Devel Ther; 2018 Jan 11; 12():2285-2292. PubMed ID: 30087553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R, Zhang Z, Wang B, Chen G, Zhang Y, Deng H, Tang Z, Mao J, Wang L.
    Drug Des Devel Ther; 2020 Jan 11; 14():2249-2261. PubMed ID: 32606595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
    Tian X, Bera H, Guo X, Xu R, Sun J, He Z, Cun D, Yang M.
    ACS Appl Mater Interfaces; 2021 Dec 08; 13(48):56858-56872. PubMed ID: 34806372
    [Abstract] [Full Text] [Related]

  • 12. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation.
    Wang J, Su G, Yin X, Luo J, Gu R, Wang S, Feng J, Chen B.
    Biomed Pharmacother; 2019 Dec 08; 120():109493. PubMed ID: 31586902
    [Abstract] [Full Text] [Related]

  • 13. Improved camptothecin encapsulation and efficacy by environmentally sensitive block copolymer/chitosan/fucoidan nanoparticles for targeting lung cancer cells.
    Don TM, Hong YT, Jheng PR, Chuang EY, Huang YC.
    Int J Biol Macromol; 2024 Oct 08; 277(Pt 2):133901. PubMed ID: 39038585
    [Abstract] [Full Text] [Related]

  • 14. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
    Liu J, Cheng H, Han L, Qiang Z, Zhang X, Gao W, Zhao K, Song Y.
    Drug Des Devel Ther; 2018 Oct 08; 12():3199-3209. PubMed ID: 30288024
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
    Chen Y, Xu Z, Lu T, Luo J, Xue H.
    Drug Deliv; 2022 Dec 08; 29(1):2705-2712. PubMed ID: 35980107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.